Home › Funds › Frazier Life Sciences Management, L.P. › VALN

Frazier Life Sciences Management, L.P. position in VALN

VALNEVA SE · Health Care

Frazier Life Sciences Management, L.P. reported holding 2,291,666 shares of VALN (VALNEVA SE) in its Q2 2026 13F filing — a position valued at US$12.0M, representing 0.26% of its reported portfolio and ranking #37 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed VALN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)2.29M sh
Reported value held$11.99M
Portfolio Weight0.26%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s VALN position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in VALN in Q2 2025 at 1,458,333 shares (US$8.2M). The position peaked in Q3 2025 at 2,291,666 shares, worth US$28.0M. Across 5 filings, Frazier Life Sciences Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,291,666 shares valued at US$12.0M. Notable position changes include a 57% increase in Q3 2025 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.46M $8.24M New
Q3 2025 2.29M $27.96M Add
Q4 2025 2.29M $20.21M Hold
Q1 2026 2.29M $14.32M Hold
Q2 2026 2.29M $11.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VALN and 13F data

VALN (VALNEVA SE) is a Health Care company. 20 other funds we track also report a position in VALN — the largest reported positions include Vivo Capital, LLC (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VALN

All VALN fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held VALN?

Frazier Life Sciences Management, L.P. has disclosed VALN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Frazier Life Sciences Management, L.P.'s current position in VALN?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 2.29M shares of VALN (VALNEVA SE), valued at $11.99M, representing 0.26% of its reported portfolio and ranking #37.

Has Frazier Life Sciences Management, L.P. been buying or selling VALN?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in VALN. The position peaked in Q3 2025 at 2.29M shares.

Which other funds hold VALN?

Other major institutional holders of VALN include Vivo Capital, LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.